Cambricon Technologies Corp Ltd
Information Technology
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
485 / 670
Position in country
6182 / 7387
Return on Assets, %
-19.7
1.6
Net income margin, %
-489
1.8
EBITDA margin, %
-386.6
9.2
Debt to Equity, %
1
17.1
Intangible assets and goodwill, %
2.6
1.1
Revenue CAGR 3Y, %
17.9
8.3
Total Equity change 1Y, %
13
-0.8
Revenue Y, % chg
-17.4
-10.2
P/BV
11.4
2.4
P/S
109.3
3.5
EV/S
106.6
3.4
EV/EBITDA
-16.8
13.4
Average Analyst recommendation
Buy
Buy
Average upside forecasts, %
-28.2
29.1
Expected dividend per share
0
0
Competitors
Ranks
-
Tongwei Co Ltd
00%
-
Jinko Solar Co Ltd
00%
-
LONGi Green Energy Technology Co Ltd
00%
-
Hygon Information Technology Co Ltd
00%
-
Semiconductor Manufacturing International Corp
00%
-
Montage Technology Co Ltd
00%
-
Will Semiconductor Co Ltd Shanghai
00%
-
Sanan Optoelectronics Co Ltd
00%
-
Silergy Corp
00%
-
Cambricon Technologies Corp Ltd
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
China
Sector
Information Technology
Industry group
Semiconductors & Semiconductor Equipment
Industry
Semiconductors & Semiconductor Equipment
Sub-sector
Information Technology
Capitalization (millions of $)
9221.4
Ticker
688256.SS
ISIN
CNE1000041R8
IPO date
2020-07-20
Availability on Russian exchanges
No
Reporting for
2023-08-30
Date fact. publication of reports
2023-06-30
Company Description
Covalon Technologies Ltd. is a Canada-based company that is a researcher, developer, manufacturer and marketer of medical products that manage patient outcomes and save lives in the areas of wound care, infection management and surgical procedures. The Company uses science and technology to help solve medical challenges associated with prevention, detection and management of areas such as infection, tissue repair and medical devices. Its products include Advanced Wound Care, Vascular Access, Perioperative Care and Urology. Advanced Wound Care is designed for the treatment of a range of wounds and offers CovaWound and ColActive brands. Vascular Access portfolio includes CovaView IV, a transparent film dressing that provides an effective barrier against external contaminants, including fluid, bacteria, and yeast. Perioperative care refers to the three Phases of surgery, including preoperative, intraoperative, and postoperative care and its brands include MediClear and SurgiClear.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: